BIM
VBIV

BlackRock Investment Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

BlackRock Investment Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$11K Hold
122
– – ﹤0.01% 3568
2016
Q3 		$13K Hold
122
– – ﹤0.01% 3505
2016
Q2 		$14K Buy
122
+81
+198% +$8.12K ﹤0.01% 3491
2016
Q1 		$3K Hold
41
– – ﹤0.01% 3922
2015
Q4 		$3K Hold
41
– – ﹤0.01% 3967
2015
Q3 		$3K Hold
41
– – ﹤0.01% 4042
2015
Q2 		$3K Buy
+41
New +$3.36K ﹤0.01% 4048

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
TFCP
Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BlackRock Investment Management's VBIV Position: Q4 2016 in Review

BlackRock Investment Management held its VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) position steady in Q4 2016 at 122 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #3568.

BlackRock Investment Management first reported a position in VBIV in Q2 2015 and has held it in 7 quarters since. The position peaked at $14K in Q2 2016. 21 funds tracked by Wall St. Rank hold VBIV as of Q4 2016.

  • BlackRock Investment Management held 122 shares of VBI Vaccines, Inc. New Common Stock (Canada) worth $11K as of Q4 2016.
  • BlackRock Investment Management left its VBI Vaccines, Inc. New Common Stock (Canada) share count unchanged in Q4 2016.
  • VBI Vaccines, Inc. New Common Stock (Canada) made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3568 holding.
  • BlackRock Investment Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Investment Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $14K in Q2 2016.
  • 21 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.